Generate Biomedicines, Inc. Announces Pricing of Initial Public Offering
Generate Biomedicines official news-release RSS · 行业原文收录 · 来源发布：Thu Feb 26 2026 23:11:00 GMT+0000 (Coordinated Universal Time) · 本站收录：Thu Oct 08 2026 09:07:27 GMT+0000 (Coordinated Universal Time)
已保存的原文节选
SOMERVILLE, Mass., February 26, 2026 — Generate Biomedicines, Inc. (Nasdaq: GENB) (“Generate”), a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development, today announced the pricing of its initial public offering of 25,000,000 shares of common stock at a public offering price of $16.00 per share. The gross proceeds from the offering
以上为带出处的原文节选，完整内容请阅读原始链接。自动收录与主题分类不等于事实核验。